Article
Cancer-associated fibroblasts drive metabolic heterogeneity in colorectal cancer cells: predictions from metabolic modeling.
NPJ systems biology and applications - 4 Mar 2026
Elton Elizabeth, Tavakoli Niki, Cetin Handan, Finley Stacey D
Abstract excerpt
KRAS-mutant colorectal cancer (CRC) undergoes metabolic reprogramming that promotes tumor progression and drug resistance. Cancer-associated fibroblasts (CAFs), a major component of the tumor microenvironment (TME), play a pivotal role in modulating these metabolic adaptations in CRC. This study applies flux sampling combined with representation learning and hierarchical clustering to a computational model of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
